Palobiofarma, S.L.
Latest round
- Series D
Last raised
- Jun 2013
Total raised
- $9.8M
Investors
- 3
About Palobiofarma, S.L.
L. operates as a biopharmaceutical company that offers drug based on the modulation of adenosine receptors that discover and develop pharmaceutical products.L.L. focuses on developing drugs that modulate adenosine receptors for various physiological processes and diseases. The company's pipeline includes multiple candidates such as PBF-680, which is an adenosine A1 receptor antagonist for asthma and COPD, recently completed a Phase II trial with positive outcomes. PBF-999, targeting Prader-Willi Syndrome, received Orphan Drug Designation from the FDA and EMA. Other notable candidates include PBF-677 for inflammatory bowel disease, PBF-1129 for idiopathic pulmonary fibrosis and lung cancer, and PBF-1650 for autoimmune diseases like psoriasis and atopic dermatitis. Palobiofarma also has PBF-509, an adenosine A2A receptor antagonist, out-licensed to Novartis for solid tumor treatment. It partners with Contract Research Organizations (CROs), research centers, and universities for pharmacology and toxicology tests essential for full compound characterization and candidate development.
Who invested in Palobiofarma, S.L.
3 investors across 3 rounds
See all investors in Palobiofarma, S.L.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Palobiofarma, S.L.
Who invested in Palobiofarma, S.L.?
Palobiofarma, S.L. has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Palobiofarma, S.L. raised?
Palobiofarma, S.L. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Palobiofarma, S.L. last raise money?
Palobiofarma, S.L.'s most recent round on record is a Series D, in Jun 2013.
What does Palobiofarma, S.L. do?
Palobiofarma, S.L. is a pharmaceuticals company.
Where is Palobiofarma, S.L. headquartered?
Palobiofarma, S.L. is headquartered in Barcelona, Spain.
Which VCs invest in companies like Palobiofarma, S.L.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Palobiofarma, S.L.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Palobiofarma, S.L.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.